GALLIVAC IB88

Nchi: Ayalandi

Lugha: Kiingereza

Chanzo: HPRA (Health Products Regulatory Authority)

Viambatanisho vya kazi:

INFECTIOUS BRONCHITIS CORONAVIRUS, STRAIN CR88121 LIVE ATTENUATED

Inapatikana kutoka:

Merial Animal Health Limited

ATC kanuni:

QI01AD07

INN (Jina la Kimataifa):

INFECTIOUS BRONCHITIS CORONAVIRUS, STRAIN CR88121 LIVE ATTENUATED

Kipimo:

4.0-5.3

Dawa fomu:

Powder for suspension for nebulization

Dawa ya aina:

POM

Kundi la matibabu:

Fowl - Chicken

Eneo la matibabu:

Avian infectious bronchitis virus vaccine

Matibabu dalili:

Immunological - Live Vaccine

Idhini hali ya:

Authorised

Idhini ya tarehe:

2003-06-23

Tabia za bidhaa

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
GALLIVAC IB88.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each dose of reconstituted vaccine contains:
Attenuated Infectious Bronchitis coronavirus, strain CR88121 (793B), at least 4.0 log
10
EID
50
Excipient q.s. 1 dose
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Powder for nebuliser suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Broiler chickens from 14 days of age.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Reduces clinical signs and lesions of respiratory disease caused by the coronavirus variant, strain CR88 (793B) in
broiler chickens.
Immunity has been demonstrated 17 days after vaccination, and the duration of immunity is at least 5 weeks.
4.3 CONTRAINDICATIONS
In the absence of trial data, furure layers or breeders and chickens in lay must not be vaccinated.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Gallivac IB88 vaccination does not replace the vaccination schedule against classical Infectious Bronchitis.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 15/06/2012_
_CRN 7012796_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Only healthy birds should be vaccinated.
The vaccine virus can spread to non-vaccinated birds, but no trend towards reversion to virulence was demonstrated in
laboratory trials. Nevertheless, care should be taken to prevent spread of vaccine virus to susceptible birds such as
replacement layers and young birds.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO THE ANIMALS
Care should be taken during reconstitution and administration of the vaccine. The operator�